Published in J Biol Chem on September 26, 1997
Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem Biol (2010) 2.27
Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus. Antimicrob Agents Chemother (2005) 1.91
Antimicrobial peptides: successes, challenges and unanswered questions. J Membr Biol (2011) 1.83
Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob Agents Chemother (2003) 1.63
Biomolecular engineering by combinatorial design and high-throughput screening: small, soluble peptides that permeabilize membranes. J Am Chem Soc (2008) 1.46
Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids (2011) 1.45
Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am J Reprod Immunol (2011) 1.40
Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications. Antimicrob Agents Chemother (2005) 1.27
Paneth cell α-defensins in enteric innate immunity. Cell Mol Life Sci (2011) 1.16
Biophysical characterization of endotoxin inactivation by NK-2, an antimicrobial peptide derived from mammalian NK-lysin. Antimicrob Agents Chemother (2004) 1.11
Influence of lipid composition on membrane activity of antimicrobial phenylene ethynylene oligomers. J Phys Chem B (2008) 1.11
Susceptibilities of oral bacteria and yeast to mammalian cathelicidins. Antimicrob Agents Chemother (2001) 1.06
Mechanisms of alpha-defensin bactericidal action: comparative membrane disruption by Cryptdin-4 and its disulfide-null analogue. Biochemistry (2008) 1.04
Paneth cell alpha-defensins: peptide mediators of innate immunity in the small intestine. Springer Semin Immunopathol (2005) 1.01
The membrane-bound structure and topology of a human α-defensin indicate a dimer pore mechanism for membrane disruption. Biochemistry (2010) 1.01
CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity. J Immunol (2012) 1.00
Anionic amino acids near the pro-alpha-defensin N terminus mediate inhibition of bactericidal activity in mouse pro-cryptdin-4. J Biol Chem (2008) 0.95
The lipid dependence of melittin action investigated by dual-color fluorescence burst analysis. Biophys J (2007) 0.95
Impact of pro segments on the folding and function of human neutrophil alpha-defensins. J Mol Biol (2007) 0.92
A membrane-translocating peptide penetrates into bilayers without significant bilayer perturbations. Biophys J (2013) 0.91
Defensins impair phagocytic killing by neutrophils in biomaterial-related infection. Infect Immun (1999) 0.89
A critical evaluation of random copolymer mimesis of homogeneous antimicrobial peptides. Macromolecules (2013) 0.84
Highly efficient macromolecule-sized poration of lipid bilayers by a synthetically evolved peptide. J Am Chem Soc (2014) 0.84
Membrane lysis by the antibacterial peptides cecropins B1 and B3: A spin-label electron spin resonance study on phospholipid bilayers. Biophys J (1999) 0.83
The insect peptide coprisin prevents Clostridium difficile-mediated acute inflammation and mucosal damage through selective antimicrobial activity. Antimicrob Agents Chemother (2011) 0.80
Synthesis, structure, and activities of an oral mucosal alpha-defensin from rhesus macaque. J Biol Chem (2008) 0.78
Membrane interaction of antimicrobial peptides using E. coli lipid extract as model bacterial cell membranes and SFG spectroscopy. Chem Phys Lipids (2015) 0.77
Determining the Effects of Membrane-Interacting Peptides on Membrane Integrity. Methods Mol Biol (2015) 0.77
Differential Susceptibility of Bacteria to Mouse Paneth Cell α-Defensins under Anaerobic Conditions. Antibiotics (Basel) (2014) 0.75
Simulations of Membrane-Disrupting Peptides II: AMP Piscidin 1 Favors Surface Defects over Pores. Biophys J (2016) 0.75
Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest (1985) 8.63
Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat Struct Biol (1996) 8.57
Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol (2000) 6.62
Structure of a fluid dioleoylphosphatidylcholine bilayer determined by joint refinement of x-ray and neutron diffraction data. III. Complete structure. Biophys J (1992) 6.46
Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect Immun (1984) 5.30
Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest (1989) 5.21
The preference of tryptophan for membrane interfaces. Biochemistry (1998) 5.10
A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science (1999) 3.90
Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci U S A (1990) 3.90
The nature of the hydrophobic binding of small peptides at the bilayer interface: implications for the insertion of transbilayer helices. Biochemistry (1989) 3.71
Primary structures of three human neutrophil defensins. J Clin Invest (1985) 3.70
Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem (1985) 3.58
Solvation energies of amino acid side chains and backbone in a family of host-guest pentapeptides. Biochemistry (1996) 3.30
Formation of "solvent-free" black lipid bilayer membranes from glyceryl monooleate dispersed in squalene. Biophys J (1978) 3.26
The development of spatial representations of large-scale environments. Adv Child Dev Behav (1975) 3.25
Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages. J Biol Chem (1983) 3.00
Direct inactivation of viruses by human granulocyte defensins. J Virol (1986) 3.00
Defensins. Eur J Haematol (1990) 2.88
How to measure and analyze tryptophan fluorescence in membranes properly, and why bother? Anal Biochem (2000) 2.79
Structure of a fluid dioleoylphosphatidylcholine bilayer determined by joint refinement of x-ray and neutron diffraction data. II. Distribution and packing of terminal methyl groups. Biophys J (1992) 2.74
Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science (1991) 2.71
Capacitance, area, and thickness variations in thin lipid films. Biochim Biophys Acta (1973) 2.53
Fluid bilayer structure determination by the combined use of x-ray and neutron diffraction. II. "Composition-space" refinement method. Biophys J (1991) 2.51
Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest (1989) 2.50
Defensins: endogenous antibiotic peptides of animal cells. Cell (1991) 2.45
Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci (1994) 2.43
Structure, function, and membrane integration of defensins. Curr Opin Struct Biol (1995) 2.40
Fluid bilayer structure determination by the combined use of x-ray and neutron diffraction. I. Fluid bilayer models and the limits of resolution. Biophys J (1991) 2.37
Antibacterial activity of microbicidal cationic proteins 1 and 2, natural peptide antibiotics of rabbit lung macrophages. Infect Immun (1983) 2.33
Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes. J Virol (1985) 2.31
Determination of the hydrocarbon core structure of fluid dioleoylphosphocholine (DOPC) bilayers by x-ray diffraction using specific bromination of the double-bonds: effect of hydration. Biophys J (1998) 2.26
Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium. Infect Immun (1990) 2.25
Energetics, stability, and prediction of transmembrane helices. J Mol Biol (2001) 2.25
Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J Clin Invest (1988) 2.18
Purification, primary structure, and antimicrobial activities of a guinea pig neutrophil defensin. Infect Immun (1987) 2.16
Folding of amphipathic alpha-helices on membranes: energetics of helix formation by melittin. J Mol Biol (1999) 2.06
Activity of rabbit leukocyte peptides against Candida albicans. Infect Immun (1985) 2.05
MPtopo: A database of membrane protein topology. Protein Sci (2001) 2.04
Paneth cell defensins: endogenous peptide components of intestinal host defense. FASEB J (1996) 2.03
In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes. Blood (1986) 2.01
The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation. Mol Cell Biol (1998) 1.98
Structure, location, and lipid perturbations of melittin at the membrane interface. Biophys J (2001) 1.96
Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect Immun (1997) 1.96
Formation of planar bilayer membranes from lipid monolayers. A critique. Biophys J (1976) 1.95
Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms. Infect Immun (1994) 1.93
Neutrophils and host defense. Ann Intern Med (1988) 1.92
Analysis of the torus surrounding planar lipid bilayer membranes. Biophys J (1972) 1.92
Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity. Infect Immun (1985) 1.89
Letter: Comments on "electrical breakdown of bimolecular lipid membranes as an electromechanical instability". Biophys J (1974) 1.87
Phase transitions in planar bilayer membranes. Biophys J (1975) 1.84
In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dis (1986) 1.84
An amphipathic alpha-helix at a membrane interface: a structural study using a novel X-ray diffraction method. J Mol Biol (1999) 1.82
Molecular packing and area compressibility of lipid bilayers. Proc Natl Acad Sci U S A (1985) 1.82
Folding of beta-sheet membrane proteins: a hydrophobic hexapeptide model. J Mol Biol (1998) 1.82
Properties of Asp212----Asn bacteriorhodopsin suggest that Asp212 and Asp85 both participate in a counterion and proton acceptor complex near the Schiff base. J Biol Chem (1991) 1.81
Studies of the physical chemistry of planar bilayer membranes using high-precision measurements of specific capacitance. Ann N Y Acad Sci (1977) 1.80
A study of lipid bilayer membrane stability using precise measurements of specific capacitance. Biophys J (1970) 1.78
Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect Immun (1994) 1.78
Membrane structures in normal and essential fatty acid-deficient stratum corneum: characterization by ruthenium tetroxide staining and x-ray diffraction. J Invest Dermatol (1991) 1.76
Sizing membrane pores in lipid vesicles by leakage of co-encapsulated markers: pore formation by melittin. Biophys J (1997) 1.76
Determining bilayer hydrocarbon thickness from neutron diffraction measurements using strip-function models. Biophys J (1986) 1.73
Designing transmembrane alpha-helices that insert spontaneously. Biochemistry (2000) 1.73
Transbilayer distribution of bromine in fluid bilayers containing a specifically brominated analogue of dioleoylphosphatidylcholine. Biochemistry (1991) 1.68
Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids. Biophys J (1997) 1.68
Protein chemistry at membrane interfaces: non-additivity of electrostatic and hydrophobic interactions. J Mol Biol (2001) 1.67
Membrane partitioning: distinguishing bilayer effects from the hydrophobic effect. Biochemistry (1993) 1.65
Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity. J Immunol (1988) 1.64
Disturbance of HL-A antigen frequency in Psoriasis. N Engl J Med (1972) 1.63
Structure and diversity of the murine cryptdin gene family. Genomics (1994) 1.62
Defensin-rich dense granules of human neutrophils. Blood (1987) 1.59
Hexane dissolved in dioleoyllecithin bilayers has a partial molar volume of approximately zero. Biochemistry (1985) 1.55
'Detergent-like' permeabilization of anionic lipid vesicles by melittin. Biochim Biophys Acta (2001) 1.53
Increased content of microbicidal cationic peptides in rabbit alveolar macrophages elicited by complete Freund adjuvant. Infect Immun (1981) 1.52
Antimicrobial activity of phagocyte granule proteins. Semin Respir Infect (1986) 1.49
Axial movement and tibial fractures. A controlled randomised trial of treatment. J Bone Joint Surg Br (1991) 1.48
Leakage of membrane vesicle contents: determination of mechanism using fluorescence requenching. Biophys J (1995) 1.47
Purification and antimicrobial properties of three defensins from rat neutrophils. Infect Immun (1989) 1.46
Small phospholipid vesicles: internal pressure, surface tension, and surface free energy. Proc Natl Acad Sci U S A (1980) 1.44
Defensins promote fusion and lysis of negatively charged membranes. Protein Sci (1993) 1.43
Purification and primary structure of murine cryptdin-1, a Paneth cell defensin. FEBS Lett (1992) 1.42
Leiomyomas of the lower respiratory tract. Thorax (1985) 1.39
Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans. Infect Immun (2000) 1.38
Defensins are mitogenic for epithelial cells and fibroblasts. J Cell Physiol (1993) 1.35
Direct measurement of salt-bridge solvation energies using a peptide model system: implications for protein stability. Proc Natl Acad Sci U S A (1996) 1.35
Mechanism of leakage of contents of membrane vesicles determined by fluorescence requenching. Methods Enzymol (1997) 1.32
Temperature-dependent structural changes in planar bilayer membranes: solvent "freeze-out". Biochim Biophys Acta (1974) 1.30
Specificity of the Oxford knee status questionnaire. The effect of disease of the hip or lumbar spine on patients' perception of knee disability. J Bone Joint Surg Br (2001) 1.26
Determining the membrane topology of peptides by fluorescence quenching. Biochemistry (2000) 1.24
Oxygen-independent bactericidal systems. Mechanisms and disorders. Hematol Oncol Clin North Am (1988) 1.21
CD spectra of indolicidin antimicrobial peptides suggest turns, not polyproline helix. Biochemistry (1999) 1.19
Obturator dislocation of the hip. J Bone Joint Surg Br (2001) 1.17
Newborn rabbit alveolar macrophages are deficient in two microbicidal cationic peptides, MCP-1 and MCP-2. Am Rev Respir Dis (1985) 1.17
Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes. Infect Immun (1999) 1.16
Childhood events recalled by children and adults. Adv Child Dev Behav (1989) 1.15
Lysozyme: primary bactericidin in human plasma serum active against Bacillus subtilis. Infect Immun (1978) 1.15